✨ Medicine Distribution Consent




NEW ZEALAND GAZETTE, No. 71 β€” 2 JULY 2015

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Levetiracetam Actavis
Levetiracetam 250mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Levetiracetam Actavis
Levetiracetam 500mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Levetiracetam Actavis
Levetiracetam 750mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Levetiracetam Actavis
Levetiracetam 1000mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Ranitidine Relief
Ranitidine hydrochloride 167.5mg equivalent to Ranitidine 150mg
Film coated tablet
Mylan New Zealand Limited
Adcock Ingram Limited – A Medreich Group Company, Bangalore, India
Medreich Limited, Bangalore, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Sylvant
Siltuximab 100mg
Powder for infusion concentrate
Janssen-Cilag (New Zealand) Limited
Cilag AG, Schaffhausen, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Sylvant
Siltuximab 400mg
Powder for infusion concentrate
Janssen-Cilag (New Zealand) Limited
Cilag AG, Schaffhausen, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Voltaren Osteo Gel 12 Hourly
Diclofenac diethylamine 2.32% equivalent to diclofenac 2%
Topical gel
Novartis Consumer Health Australasia Pty Limited (New Zealand)
Novartis Consumer Health SA, Nyon, Switzerland

Dated this 26th day of June 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2015-go3848

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

43



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2015, No 71





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
26 June 2015
Medicines, Consent, Distribution, Levetiracetam, Ranitidine, Sylvant, Voltaren
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
Medicines, Consent, Distribution